A mouse model for South African (R59W) variegate porphyria

construction and initial characterization.

Amy Elizabeth Medlock, Peter N. Meissner, Brandon P. Davidson, Anne V. Corrigall, Harry A. Dailey

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Variegate porphyria is inherited as an autosomal dominant disease with variable penetrance. It is characterized clinically by photocutaneous sensitivity and acute neurovisceral attacks, and biochemically by abnormal porphyrin excretion in the urine and feces. While the world-wide incidence of variegate porphyria is relatively low, in South Africa it is one of the most common genetic diseases in humans. Due to the large number of patients with variegate porphyria in South Africa, and the fact that variegate porphyria is representative of both the so-called "acute" and the "photocutaneous" porphyrias, it would be valuable to have an animal model in which to study the disease. In this study we have produced a mouse model of "South African" variegate porphyria with the R59W mutation in C57/BL6 mice via targeted gene replacement. Hepatic protoporphyrinogen oxidase activity was reduced by approximately 50% in mice heterozygous for the mutation. Urine and fecal samples from these mice, in the absence of exogenous inducers of hepatic haem synthesis, contain elevated concentrations of porphyrins and porphyrin precursors in a pattern similar to that found in human variegate porphyric subjects. Bypassing the rate-limiting step in haem biosynthesis by feeding 5-aminolevulinic acid to these mice, results in an accentuated porphyrin excretory pattern characteristic of the variegate porphyric phenotype and urinary porphobilinogen is increased significantly. This initial characterization of these mice suggest that they are a good model for variegate porphyria at the biochemical level.

Original languageEnglish (US)
Pages (from-to)71-78
Number of pages8
JournalCellular and molecular biology (Noisy-le-Grand, France)
Volume48
Issue number1
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Variegate Porphyria
Porphyrins
Heme
Protoporphyrinogen Oxidase
Porphobilinogen
South Africa
Aminolevulinic Acid
Biosynthesis
Urine
Acute Intermittent Porphyria
Mutation
Inborn Genetic Diseases
Animals
Penetrance
Genes
Liver
Feces
Animal Models
Phenotype
Incidence

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Medlock, A. E., Meissner, P. N., Davidson, B. P., Corrigall, A. V., & Dailey, H. A. (2002). A mouse model for South African (R59W) variegate porphyria: construction and initial characterization. Cellular and molecular biology (Noisy-le-Grand, France), 48(1), 71-78.

A mouse model for South African (R59W) variegate porphyria : construction and initial characterization. / Medlock, Amy Elizabeth; Meissner, Peter N.; Davidson, Brandon P.; Corrigall, Anne V.; Dailey, Harry A.

In: Cellular and molecular biology (Noisy-le-Grand, France), Vol. 48, No. 1, 01.01.2002, p. 71-78.

Research output: Contribution to journalArticle

Medlock, AE, Meissner, PN, Davidson, BP, Corrigall, AV & Dailey, HA 2002, 'A mouse model for South African (R59W) variegate porphyria: construction and initial characterization.', Cellular and molecular biology (Noisy-le-Grand, France), vol. 48, no. 1, pp. 71-78.
Medlock, Amy Elizabeth ; Meissner, Peter N. ; Davidson, Brandon P. ; Corrigall, Anne V. ; Dailey, Harry A. / A mouse model for South African (R59W) variegate porphyria : construction and initial characterization. In: Cellular and molecular biology (Noisy-le-Grand, France). 2002 ; Vol. 48, No. 1. pp. 71-78.
@article{565a3620dda34d5aa0a75ab016daf30f,
title = "A mouse model for South African (R59W) variegate porphyria: construction and initial characterization.",
abstract = "Variegate porphyria is inherited as an autosomal dominant disease with variable penetrance. It is characterized clinically by photocutaneous sensitivity and acute neurovisceral attacks, and biochemically by abnormal porphyrin excretion in the urine and feces. While the world-wide incidence of variegate porphyria is relatively low, in South Africa it is one of the most common genetic diseases in humans. Due to the large number of patients with variegate porphyria in South Africa, and the fact that variegate porphyria is representative of both the so-called {"}acute{"} and the {"}photocutaneous{"} porphyrias, it would be valuable to have an animal model in which to study the disease. In this study we have produced a mouse model of {"}South African{"} variegate porphyria with the R59W mutation in C57/BL6 mice via targeted gene replacement. Hepatic protoporphyrinogen oxidase activity was reduced by approximately 50{\%} in mice heterozygous for the mutation. Urine and fecal samples from these mice, in the absence of exogenous inducers of hepatic haem synthesis, contain elevated concentrations of porphyrins and porphyrin precursors in a pattern similar to that found in human variegate porphyric subjects. Bypassing the rate-limiting step in haem biosynthesis by feeding 5-aminolevulinic acid to these mice, results in an accentuated porphyrin excretory pattern characteristic of the variegate porphyric phenotype and urinary porphobilinogen is increased significantly. This initial characterization of these mice suggest that they are a good model for variegate porphyria at the biochemical level.",
author = "Medlock, {Amy Elizabeth} and Meissner, {Peter N.} and Davidson, {Brandon P.} and Corrigall, {Anne V.} and Dailey, {Harry A.}",
year = "2002",
month = "1",
day = "1",
language = "English (US)",
volume = "48",
pages = "71--78",
journal = "Cellular and Molecular Biology",
issn = "0145-5680",
publisher = "Cellular and Molecular Biology Association",
number = "1",

}

TY - JOUR

T1 - A mouse model for South African (R59W) variegate porphyria

T2 - construction and initial characterization.

AU - Medlock, Amy Elizabeth

AU - Meissner, Peter N.

AU - Davidson, Brandon P.

AU - Corrigall, Anne V.

AU - Dailey, Harry A.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Variegate porphyria is inherited as an autosomal dominant disease with variable penetrance. It is characterized clinically by photocutaneous sensitivity and acute neurovisceral attacks, and biochemically by abnormal porphyrin excretion in the urine and feces. While the world-wide incidence of variegate porphyria is relatively low, in South Africa it is one of the most common genetic diseases in humans. Due to the large number of patients with variegate porphyria in South Africa, and the fact that variegate porphyria is representative of both the so-called "acute" and the "photocutaneous" porphyrias, it would be valuable to have an animal model in which to study the disease. In this study we have produced a mouse model of "South African" variegate porphyria with the R59W mutation in C57/BL6 mice via targeted gene replacement. Hepatic protoporphyrinogen oxidase activity was reduced by approximately 50% in mice heterozygous for the mutation. Urine and fecal samples from these mice, in the absence of exogenous inducers of hepatic haem synthesis, contain elevated concentrations of porphyrins and porphyrin precursors in a pattern similar to that found in human variegate porphyric subjects. Bypassing the rate-limiting step in haem biosynthesis by feeding 5-aminolevulinic acid to these mice, results in an accentuated porphyrin excretory pattern characteristic of the variegate porphyric phenotype and urinary porphobilinogen is increased significantly. This initial characterization of these mice suggest that they are a good model for variegate porphyria at the biochemical level.

AB - Variegate porphyria is inherited as an autosomal dominant disease with variable penetrance. It is characterized clinically by photocutaneous sensitivity and acute neurovisceral attacks, and biochemically by abnormal porphyrin excretion in the urine and feces. While the world-wide incidence of variegate porphyria is relatively low, in South Africa it is one of the most common genetic diseases in humans. Due to the large number of patients with variegate porphyria in South Africa, and the fact that variegate porphyria is representative of both the so-called "acute" and the "photocutaneous" porphyrias, it would be valuable to have an animal model in which to study the disease. In this study we have produced a mouse model of "South African" variegate porphyria with the R59W mutation in C57/BL6 mice via targeted gene replacement. Hepatic protoporphyrinogen oxidase activity was reduced by approximately 50% in mice heterozygous for the mutation. Urine and fecal samples from these mice, in the absence of exogenous inducers of hepatic haem synthesis, contain elevated concentrations of porphyrins and porphyrin precursors in a pattern similar to that found in human variegate porphyric subjects. Bypassing the rate-limiting step in haem biosynthesis by feeding 5-aminolevulinic acid to these mice, results in an accentuated porphyrin excretory pattern characteristic of the variegate porphyric phenotype and urinary porphobilinogen is increased significantly. This initial characterization of these mice suggest that they are a good model for variegate porphyria at the biochemical level.

UR - http://www.scopus.com/inward/record.url?scp=0036481425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036481425&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 71

EP - 78

JO - Cellular and Molecular Biology

JF - Cellular and Molecular Biology

SN - 0145-5680

IS - 1

ER -